Home › Compare › GRUPF vs ABBV
GRUPF yields 1.77% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, GRUPF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRUPF + ABBV for your $10,000?
Fnac Darty SA engages in the retail of entertainment and leisure products, consumer electronics, and domestic appliances in France and Switzerland, Belgium and Luxembourg, and the Iberian Peninsula. The company offers consumer electronics, including desktop computers, laptops, tablets, software, printers, e-readers, telephones and office products, and accessories, as well as various connected products; cameras and photography accessories; televisions and video accessories, such as DVD players, Blu-Ray players, and other accessories; and audio items and accessories comprising MP3 players, headphones, docking stations, and related accessories. It also provides editorial products that include hard copy and digital books; discs comprising music CDs, and video DVDs, and Blu-Ray discs; video games and gaming consoles; and gadgets, T-shirts, musical instruments, and others. In addition, the company offers refrigerators/freezers, cooking equipment, dishwashers, and washing machines/dryers; vacuum cleaners, food processors, and body care and water/air treatment appliances; and kitchen units, home and design products, games and toys, urban mobility, stationery, and wellbeing products. Further, it provides warranty extension, product insurance sale, repair-related subscription sale, after-sale, and delivery and installation services; rental services for consumer electronics and delivery services; ticketing and gift boxes; and membership cards for the company's loyalty programs. The company sells its products through its stores and e-commerce websites. It operates 957 points of sale, including 390 franchises. The company was founded in 1954 and is headquartered in Ivry-sur-Seine, France.
Full GRUPF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.